Biochemistry & Analytical Biochemistry

Peixuan Guo

Biography

 Peixuan Guo, one of the top three nanobiotechnology experts in the world, recently joined the University of Kentucky, where he shares a joint appointment as a professor and William Farish Endowed Chair of Nanobiotechnology in UK College of Pharmacy and Markey Cancer Center, and serves as the Director of Nanobiotechnology Center. He brings four research faculty members, five postdoctoral fellows, and 11 graduate students with him, along with more than $10 million in research funding and equipments. Guo has been the director of a NIH Nanomedicine Development Center, one of only eight such centers in the country. He is currently directing the National Cancer Institute Cancer Nanotechnology Platform Partnership Program with a focus on RNA Nanotechnology for Cancer Therapy.  He is co-founder of Kylin Therapeutics, Inc, and Biomotor and Nucleic Acid Nanotechnology Development, LTD.

Research Interest

 Nanobiotechnology, including structure, function and applications of phi29 DNA-packaging nanomotor, RNA Nanotechnology for siRNA/drug delivery, single molecule imaging and single molecule optical instrumentation; single pore sensing and singe pore high through DNA sequencing using phi29 DNA packaging motor